Apyx Medical Corporation Total Assets 2011-2026 | APYX

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Apyx Medical Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66.8 M	64.8 M	79.2 M	51.8 M	68.7 M	74.1 M	84.7 M	95.6 M	31 M	35.1 M	31.4 M	24.8 M	33.2 M	28.2 M	28.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
95.6 M	24.8 M	53.2 M

Quarterly Total Assets Apyx Medical Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
57.4 M	58.2 M	60.2 M	64.8 M	60.7 M	65.4 M	-	79.2 M	59.4 M	-	56.8 M	51.8 M	55.3 M	59.5 M	63 M	68.7 M	67.8 M	69.6 M	71.1 M	74.1 M	74.1 M	74.1 M	74.1 M	84.7 M	84.7 M	84.7 M	84.7 M	95.9 M	95.6 M	95.6 M	95.6 M	31 M	31 M	31 M	31 M	35.1 M	35.1 M	35.1 M	35.1 M	31.4 M	31.4 M	31.4 M	31.4 M	24.8 M	24.8 M	24.8 M	24.8 M	33.2 M	33.2 M	33.2 M	33.2 M	28.2 M	28.2 M	28.2 M	28.2 M	28.2 M	28.2 M	28.2 M	28.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
95.9 M	24.8 M	51.5 M

Total Assets of other stocks in the Medical devices industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
ClearPoint Neuro CLPT	97.7 M	$ 9.23	-1.6 %	$ 261 M	USA
GenMark Diagnostics, Inc. GNMK	224 M	-	-	$ 1.77 B	USA
EDAP TMS S.A. EDAP	91.5 M	$ 3.46	-	$ 130 M	France
Acutus Medical AFIB	54 M	-	-26.83 %	$ 2.62 M	USA
AdaptHealth Corp. AHCO	4.32 B	$ 12.07	-	$ 1.63 B	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
FONAR Corporation FONR	199 M	$ 18.6	-	$ 122 M	USA
Obalon Therapeutics, Inc. OBLN	10.6 M	-	-5.86 %	$ 30.6 M	USA
Bruker Corporation BRKR	5.81 B	$ 36.66	-0.22 %	$ 5.46 K	USA
Globus Medical GMED	5.3 B	$ 90.0	1.58 %	$ 12.2 B	USA
Helius Medical Technologies HSDT	7.69 M	$ 1.81	-4.74 %	$ 1.1 M	USA
Integra LifeSciences Holdings Corporation IART	4.04 B	$ 9.25	-0.64 %	$ 712 M	USA
Apollo Endosurgery APEN	110 M	-	-	$ 475 M	USA
Inspire Medical Systems INSP	907 M	$ 54.21	0.13 %	$ 1.59 B	USA
Integer Holdings Corporation ITGR	3.41 B	$ 85.77	0.16 %	$ 2.98 B	USA
OrthoPediatrics Corp. KIDS	509 M	$ 15.78	-1.0 %	$ 370 M	USA
IRIDEX Corporation IRIX	29.2 M	$ 1.01	1.85 %	$ 17.1 M	USA
LENSAR LNSR	71.4 M	$ 5.82	-1.27 %	$ 69.6 M	USA
Medtronic PLC MDT	91.7 B	$ 86.12	-0.19 %	$ 111 B	USA
CryoLife, Inc. CRY	789 M	-	-4.14 %	$ 702 M	USA
Avinger AVGR	13.8 M	-	-20.74 %	$ 369 K	USA
Myomo MYO	38.6 M	$ 0.67	-4.9 %	$ 28 M	USA
Align Technology ALGN	6.21 B	$ 167.26	-2.69 %	$ 12.5 B	USA
AxoGen AXGN	222 M	$ 31.33	-4.03 %	$ 1.44 B	USA
Orthofix Medical OFIX	851 M	$ 11.58	-1.61 %	$ 459 M	Curacao
Axonics Modulation Technologies AXNX	659 M	-	-	$ 3.31 B	USA
Aziyo Biologics AZYO	62.4 M	-	1.37 %	$ 20.5 M	USA
Penumbra PEN	1.83 B	$ 329.2	-0.2 %	$ 12.8 B	USA
Soliton, Inc. SOLY	33.8 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	10.5 K	-	-1.98 %	$ 98.3 M	USA
Insulet Corporation PODD	3.19 B	$ 203.09	-0.2 %	$ 14.3 B	USA
Itamar Medical Ltd. ITMR	64.1 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	204 M	-	-	$ 462 M	USA
Neovasc NVCN	66.2 M	-	-	$ 111 M	Canada
Sintx Technologies SINT	9.51 M	$ 2.49	-1.58 %	$ 6.91 M	USA
Butterfly Network BFLY	256 M	$ 4.03	-2.42 %	$ 853 M	USA
Smith & Nephew plc SNN	10.5 B	$ 31.88	-2.3 %	$ 23.8 B	Britain
Intersect ENT, Inc. XENT	227 M	-	-	$ 955 M	USA
Stryker Corporation SYK	47.8 B	$ 331.18	-0.34 %	$ 127 B	USA
Cytosorbents Corporation CTSO	44.2 M	$ 0.59	0.69 %	$ 36.7 M	USA
Tactile Systems Technology TCMD	274 M	$ 24.49	-0.33 %	$ 560 M	USA
TELA Bio TELA	81.4 M	$ 0.62	-2.08 %	$ 29.1 M	USA
TransMedics Group TMDX	1.07 B	$ 104.84	0.04 %	$ 3.56 B	USA
BIOLASE BIOL	35.1 M	-	-13.19 %	$ 166 K	USA
Tandem Diabetes Care TNDM	881 M	$ 19.55	1.98 %	$ 1.33 B	USA
Delcath Systems DCTH	124 M	$ 9.61	-0.98 %	$ 344 M	USA
BioSig Technologies BSGM	188 M	-	37.08 %	$ 85.7 M	USA
Boston Scientific Corporation BSX	43.7 B	$ 61.27	-2.11 %	$ 90.7 B	USA